Investing Profile

Daniel van den Bergh(45)

VC
Healthcare technology investor at Kaiser Permanente Ventures
kpventures.comSan Francisco, California
Photo of Daniel van den Bergh, Partner at Kaiser Permanente Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Picture
Picture
Picture

6 Investors

Connected to Gyan Kapur (Surface Ventures), Scott Barclay (Insight Partners), Shruti Gandhi (Array Ventures), and 3 other investors on Signal.

Cornell University Network
131 CONNECTIONS
The Wharton School Network
109 CONNECTIONS
cb
$7.0M - $15.0M
$10.0M
12
$141M
CompanyStageDateRound SizeTotal Raised
SureCo
Series AJul 2025$23M
$46M
Co-investors: Saurabh Bhansali (Health Velocity Capital)
HealthJoy
Series DOct 2022$60M
$130M
Co-investors: Stuart Larkins (Chicago Ventures), Aneesha Mehta (Valspring Capital), Martin Alexander Gershon (Endeavor Venture Funds), Saurabh Bhansali (Health Velocity Capital), Jack Boren
NOCD
Series BSep 2021$33M
$84M
Co-investors: Jon Lim (F-Prime Capital Partners), Glen Tullman (7wire Ventures), Alyssa Jaffee (7wire Ventures)
Ordr
Series BMar 2020$34M
$120M
Co-investors: Dharmesh Thakker (Battery Ventures), Alex Doll (Ten Eleven Ventures), René Bonvanie (Cyberstarts VC), Pankaj Patel, Daniel Warmenhoven
Nuvolo
Series BJul 2019$12M
$54M
Co-investors: Richard Wells (Insight Partners), Henry Frankievich (Insight Partners), Noah Lewis (GE Ventures)
NextHealth Technologies
Series BMar 2019$20M
$20M
Collective Medical Technologies
Series ANov 2017$48M
$48M
Co-investors: Ambar Bhattacharyya (Maverick Capital), Noah Knauf (Bond), Jack Boren
Protenus
Series AJul 2017$7M
$66M
Co-investors: Jon Lim (F-Prime Capital Partners), Patrick Meenan (Arthur Ventures)
Enterprise healthcare IT, digital health, tech-enabled healthcare services, medical technology
new molecule risk
Senior Investment Director Kaiser Permanente Ventures2024 - Present
Senior Investment Director Endeavour Vision2022 - 2024
Investment Director Kaiser Permanente Ventures2017 - 2022
Director, Strategy & Operations Lumiata2015 - 2017
Summer Associate Longitude Capital2014 - 2014
Associate, Venture Capital Safeguard Scientifics2011 - 2013
Associate, Healthcare M&A EC Mergers & Acquisitions2009 - 2011
Analyst, Investment Banking Citigroup Global Markets2007 - 2009
Summer Analyst Lux Capital2006 - 2006
The Wharton School MBA Healthcare and entrepreneurship
Cornell University BS Biological Engineering